AIM ImmunoTech, Inc. (AIM)
0.1626
-0.01
(-4.35%)
USD |
NYAM |
Oct 22, 16:00
0.1626
0.00 (0.00%)
After-Hours: 16:13
AIM ImmunoTech Market Cap : 4.714M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 4.928M |
| October 20, 2026 | 4.818M |
| October 19, 2026 | 4.728M |
| October 16, 2026 | 4.873M |
| October 15, 2026 | 4.937M |
| October 14, 2026 | 4.691M |
| October 13, 2026 | 4.925M |
| October 12, 2026 | 5.143M |
| October 09, 2026 | 5.218M |
| October 08, 2026 | 5.207M |
| October 07, 2026 | 5.299M |
| October 06, 2026 | 5.291M |
| October 05, 2026 | 5.508M |
| October 02, 2026 | 5.218M |
| October 01, 2026 | 5.441M |
| September 30, 2026 | 5.073M |
| September 29, 2026 | 5.030M |
| September 28, 2026 | 5.346M |
| September 25, 2026 | 5.511M |
| September 24, 2026 | 5.894M |
| September 23, 2026 | 6.088M |
| September 22, 2026 | 6.250M |
| September 21, 2026 | 6.073M |
| September 18, 2026 | 6.015M |
| September 17, 2026 | 6.300M |
| Date | Value |
|---|---|
| September 16, 2026 | 6.146M |
| September 15, 2026 | 6.192M |
| September 14, 2026 | 6.462M |
| September 11, 2026 | 6.427M |
| September 10, 2026 | 6.578M |
| September 09, 2026 | 6.760M |
| September 08, 2026 | 6.659M |
| September 04, 2026 | 6.598M |
| September 03, 2026 | 6.775M |
| September 02, 2026 | 6.801M |
| September 01, 2026 | 6.842M |
| August 31, 2026 | 6.552M |
| August 28, 2026 | 7.491M |
| August 27, 2026 | 7.248M |
| August 26, 2026 | 7.248M |
| August 25, 2026 | 7.364M |
| August 24, 2026 | 7.364M |
| August 21, 2026 | 7.491M |
| August 20, 2026 | 7.337M |
| August 19, 2026 | 6.905M |
| August 18, 2026 | 6.781M |
| August 17, 2026 | 7.045M |
| August 14, 2026 | 6.375M |
| August 13, 2026 | 7.497M |
| August 12, 2026 | 7.450M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.495B |
| Alnylam Pharmaceuticals, Inc. | 30.40B |
| Anika Therapeutics, Inc. | 281.24M |
| Savara, Inc. | 932.51M |
| Vericel Corp. | 2.199B |
Market Cap Related Metrics
| PS Ratio | 11.40 |
| Price to Book Value | 0.6087 |
| Price | 0.1626 |
| Earnings Yield | -2.36K% |